CLINICAL STUDY: HYPERTENSION
Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension
Kathryn E. Ferrier, BSc(Hons)*,
Michael H. Muhlmann, MBBS, FRACP*,
Jean-Philippe Baguet, MD, PhD*,
James D. Cameron, MD, MEngSc*,
Garry L. Jennings, MD, FRACP*,
Anthony M. Dart, BChBM, DPhil, FRCP* and
Bronwyn A. Kingwell, PhD*,*
* Alfred and Baker Medical Unit, Baker Medical Research Institute, Melbourne, Victoria, Australia
Manuscript received July 31, 2001;
revised manuscript received December 20, 2001,
accepted January 2, 2002.
* Reprint requests and correspondence: Dr. Bronwyn Kingwell, Alfred and Baker Medical Unit, Baker Medical Research Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne, Victoria 8008, Australia. b.kingwell{at}alfred.org.au
OBJECTIVES: We sought to investigate the effects of intensive cholesterol reduction on large artery stiffness and blood pressure in normolipidemic patients with isolated systolic hypertension (ISH).
BACKGROUND: Isolated systolic hypertension is associated with elevated cardiovascular morbidity and mortality and is primarily due to large artery stiffening, which has been independently related to cardiovascular mortality. Cholesterol-lowering therapy has been efficacious in reducing arterial stiffness in patients with hypercholesterolemia, and thus may be beneficial in ISH.
METHODS: In a randomized, double-blinded, cross-over study design, 22 patients with stage I ISH received three months of atorvastatin therapy (80 mg/day) and three months of placebo treatment. Systemic arterial compliance was measured noninvasively using carotid applanation tonometry and Doppler velocimetry of the ascending aorta.
RESULTS: Atorvastatin treatment reduced total and low-density lipoprotein cholesterol and triglyceride levels by 36 ± 2% (p < 0.001), 48 ± 3% (p < 0.001) and 23 ± 5% (p = 0.003), respectively, and increased high density lipoprotein cholesterol by 7 ± 3% (p = 0.03). Systemic arterial compliance was higher after treatment (placebo vs. atorvastatin: 0.36 ± 0.03 vs. 0.43 ± 0.05 ml/mm Hg, p = 0.03). Brachial systolic blood pressure was lower after atorvastatin treatment (154 ± 3 vs. 148 ± 2 mm Hg, p = 0.03), as were mean (111 ± 2 vs. 107 ± 2 mm Hg, p = 0.04) and diastolic blood pressures (83 ± 1 vs. 81 ± 2 mm Hg, p = 0.04). There was a trend toward a reduction in pulse pressure (71 ± 3 vs. 67 ± 2 mm Hg, p = 0.08).
CONCLUSIONS: Intensive cholesterol reduction may be beneficial in the treatment of patients with ISH and normal lipid levels, through a reduction in large artery stiffness.
|
Abbreviations and Acronyms
| | LVIDD | | ALT | | alanine aminotransferase | | AST | | aspartate aminotransferase | | DBP | | diastolic blood pressure | | HDL | | high density lipoprotein | | ISH | | isolated systolic hypertension | | LDL | | low density lipoprotein | | LVIDD | | left ventricular internal end-diastolic diameter | | LVIDS | | left ventricular internal end-systolic diameter | | MAP | | mean arterial pressure | | SAC | | systemic arterial compliance | | SBP | | systolic blood pressure | | TPR | | total peripheral resistance |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Briones, N. Rodriguez-Criado, R. Hernanz, A. B. Garcia-Redondo, R. R. Rodrigues-Diez, M. J. Alonso, J. Egido, M. Ruiz-Ortega, and M. Salaices
Atorvastatin Prevents Angiotensin II-Induced Vascular Remodeling and Oxidative Stress
Hypertension,
July 1, 2009;
54(1):
142 - 149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Williams, P. S. Lacy, J. K. Cruickshank, D. Collier, A. D. Hughes, A. Stanton, S. Thom, H. Thurston, and for the CAFE and ASCOT Investigators
Impact of Statin Therapy on Central Aortic Pressures and Hemodynamics: Principal Results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study
Circulation,
January 6, 2009;
119(1):
53 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Golomb, J. E. Dimsdale, H. L. White, J. B. Ritchie, and M. H. Criqui
Reduction in Blood Pressure With Statins: Results From the UCSD Statin Study, a Randomized Trial
Arch Intern Med,
April 14, 2008;
168(7):
721 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mangat, S. Agarwal, and C. Rosendorff
Do Statins Lower Blood Pressure?
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2007;
12(2):
112 - 123.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Strazzullo, S. M. Kerry, A. Barbato, M. Versiero, L. D'Elia, and F. P. Cappuccio
Do Statins Reduce Blood Pressure?: A Meta-Analysis of Randomized, Controlled Trials
Hypertension,
April 1, 2007;
49(4):
792 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Khoshdel, S. L. Carney, B. R. Nair, and A. Gillies
Better Management of Cardiovascular Diseases by Pulse Wave Velocity: Combining Clinical Practice with Clinical Research using Evidence-Based Medicine
Clin. Med. Res.,
March 1, 2007;
5(1):
45 - 52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Vlachopoulos, K Aznaouridis, and C Stefanadis
Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece
Heart,
November 1, 2006;
92(11):
1544 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Harloff, C. Strecker, M. Reinhard, M. Kollum, M. Handke, M. Olschewski, C. Weiller, and A. Hetzel
Combined Measurement of Carotid Stiffness and Intima-Media Thickness Improves Prediction of Complex Aortic Plaques in Patients With Ischemic Stroke
Stroke,
November 1, 2006;
37(11):
2708 - 2712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hulten, J. L. Jackson, K. Douglas, S. George, and T. C. Villines
The Effect of Early, Intensive Statin Therapy on Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials.
Arch Intern Med,
September 25, 2006;
166(17):
1814 - 1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Douglas, P. G. O'Malley, and J. L. Jackson
Meta-Analysis: The Effect of Statins on Albuminuria
Ann Intern Med,
July 18, 2006;
145(2):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A.J. van der Linde, E. J.G. Sijbrands, F. Boomsma, and A. H. van den Meiracker
Effect of Low-Density Lipoprotein Cholesterol on Angiotensin II Sensitivity: A Randomized Trial With Fluvastatin
Hypertension,
June 1, 2006;
47(6):
1125 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Halperin, H. D. Sesso, J. Ma, J. E. Buring, M. J. Stampfer, and J. Michael Gaziano
Dyslipidemia and the Risk of Incident Hypertension in Men
Hypertension,
January 1, 2006;
47(1):
45 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Sesso, J. E. Buring, M. J. Chown, P. M Ridker, and J. M. Gaziano
A Prospective Study of Plasma Lipid Levels and Hypertension in Women
Arch Intern Med,
November 14, 2005;
165(20):
2420 - 2427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Sankatsing, S. W. Fouchier, S. de Haan, B. A. Hutten, E. de Groot, J. J.P. Kastelein, and E. S.G. Stroes
Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2005;
25(9):
1979 - 1984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fukuta, D. C. Sane, S. Brucks, and W. C. Little
Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure: A Preliminary Report
Circulation,
July 19, 2005;
112(3):
357 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Kass
Ventricular Arterial Stiffening: Integrating the Pathophysiology
Hypertension,
July 1, 2005;
46(1):
185 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. V. Nair, L. A. Chaput, E. Vittinghoff, D. M. Herrington, and for the Heart and Estrogen/Progestin Replacement S
Pulse Pressure and Cardiovascular Events in Postmenopausal Women With Coronary Heart Disease
Chest,
May 1, 2005;
127(5):
1498 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. V. Nair, D. Waters, W. Rogers, G. J. Kowalchuk, T. D. Stuckey, and D. M. Herrington
Pulse Pressure and Coronary Atherosclerosis Progression in Postmenopausal Women
Hypertension,
January 1, 2005;
45(1):
53 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.C. Sposito
Emerging insights into hypertension and dyslipidaemia synergies
Eur. Heart J. Suppl.,
December 1, 2004;
6(suppl_G):
G8 - G12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Van Doornum, G McColl, and I P Wicks
Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis
Ann Rheum Dis,
December 1, 2004;
63(12):
1571 - 1575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. B. Wilkinson, S. S. Franklin, and J. R. Cockcroft
Nitric Oxide and the Regulation of Large Artery Stiffness: From Physiology to Pharmacology
Hypertension,
August 1, 2004;
44(2):
112 - 116.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Yasmin, C. M. McEniery, S. Wallace, I. S. Mackenzie, J. R. Cockcroft, and I. B. Wilkinson
C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2004;
24(5):
969 - 974.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. M. Dart, C. D. Gatzka, J. D. Cameron, B. A. Kingwell, Y.-L. Liang, K. L. Berry, C. M. Reid, and G. L. Jennings
Large Artery Stiffness Is Not Related to Plasma Cholesterol in Older Subjects with Hypertension
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2004;
24(5):
962 - 968.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. I. Osende, M. Ruiz-Ortega, L. M. Blanco-Colio, and J. Egido
Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study
Nephrol. Dial. Transplant.,
March 1, 2004;
19(3):
528 - 531.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Sposito, S. Gonbert, E. Bruckert, M. Atassi, I. Beucler, S. Amsellem, O. Khallouf, P. Benlian, and G. Turpin
Magnitude of HDL Cholesterol Variation After High-Dose Atorvastatin Is Genetically Determined at the LDL Receptor Locus in Patients With Homozygous Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2003;
23(11):
2078 - 2082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lerman and J. Herrmann
Endothelial function under pressure
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1759 - 1760.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Oliver and D. J. Webb
Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2003;
23(4):
554 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Cockcroft and I. B. Wilkinson
reliability of transfer function in determining central pulse pressure and augmentation index: Reply
J. Am. Coll. Cardiol.,
September 18, 2002;
40(6):
1196 - 1197.
[Full Text]
[PDF]
|
 |
|
|